Trial
NCT03451435
N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Los Angeles
Collaborators
—
Condition
Endodontic Disease
Intervention
N acetyl cysteine
Why stopped
Enrollment difficulties
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-21